Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.8B | 16.7B | 13.6B | 24.2B |
Cost of revenue | 6.6B | 10.1B | 9.3B | 15.4B |
Gross profit | 5.2B | 6.6B | 4.4B | 8.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.6B | 1.1B | 817M | 1.5B |
Operating income | 2.4B | 5.1B | 3.2B | 7.0B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 134.1M | 83.1M | 36.2M | 18.9M |
Other income expense | — | — | — | — |
Pretax income | 2.4B | 5.2B | 4.2B | 7.0B |
Tax provision | 427.4M | 1.3B | 1.2B | 1.5B |
Net income | 2.0B | 3.9B | 3.0B | 5.6B |
Basic EPS | — | 7.6 | 5.9 | 11.1 |
Diluted EPS | — | 7.0 | 5.4 | 11.0 |
Basic average shares | — | 515.6M | 512.4M | 504.0M |
Diluted average shares | — | 553.0M | 553.9M | 508.6M |
EBITDA | 2.6B | 5.3B | 4.3B | 7.1B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |